Orion Oyj Logo

Orion Oyj

ORNAV | HE

Overview

Corporate Details

ISIN(s):
FI0009014377 (+1 more)
LEI:
74370029VAHCXDR7B745
Country:
Finland
Address:
Orionintie 1, FI-02200 ESPOO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs). The company's research and development activities are focused on translating science into novel therapies, with a primary emphasis on oncology and pain management. Its product portfolio includes proprietary prescription drugs, generic medications, and over-the-counter (OTC) products. With over a century of experience, Orion is dedicated to 'building well-being' by developing innovative treatments and diagnostic tests for a global market.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Orion Oyj. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 08:00
Share Issue/Capital Change
337 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-08-20 08:00
Share Issue/Capital Change
337,000 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-08-08 08:30
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Juhani Kankaanpää
Finnish 4.9 KB
2025-08-08 08:30
Director's Dealing
Orion Corporation: Managers' transactions - Juhani Kankaanpää
English 4.8 KB
2025-08-04 15:10
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Satu Ahomäki
Finnish 3.5 KB
2025-08-04 15:10
Director's Dealing
Orion Corporation: Managers' transactions - Satu Ahomäki
English 3.5 KB
2025-07-18 11:00
Interim Report
Orion-konsernin puolivuosikatsaus tammi-kesäkuu 2025
Finnish 18.4 KB
2025-07-18 11:00
Earnings Release
Orion Group Half-Year Financial Report January-June 2025
English 18.3 KB
2025-07-18 08:30
Report Publication Announcement
Orion-konsernin tulosjulkistukset ja yhtiökokous vuonna 2026
Finnish 3.4 KB
2025-07-18 08:30
Report Publication Announcement
Orion Corporation's financial reporting and Annual General Meeting in 2026
English 3.6 KB
2025-07-09 12:00
Management Discussion and Analysis
Sisäpiiritieto: Orion parantaa näkymäarviota vuodelle 2025
Finnish 3.5 KB
2025-07-09 12:00
Earnings Release
Inside information: Orion upgrades full-year outlook for 2025
English 3.6 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141 959 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141,959 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-05-08 14:30
Major Shareholding Notification
Orion Corporation: Disclosure Under..
Finnish 5.6 KB

Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Orion Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Alkaloid AD Logo
Manufacturing pharmaceuticals, cosmetics, and botanicals for consumer and healthcare markets.
North Macedonia ALK
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom AGY
Israel KVSR
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain ALM
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg ALVO
Amphastar Pharmaceuticals Inc. Logo United States of America AMPH
Develops approved cannabinoid medicines for complex, chronic conditions like pain and epilepsy.
United Kingdom N/A
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN
AnGes, Inc. Logo Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR